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ARTICLE
Impact of delivery mode-associated gut microbiota
dynamics on health in the ﬁrst year of life
Marta Reyman 1,2, Marlies A. van Houten2, Debbie van Baarle3, Astrid A.T.M. Bosch1, Wing Ho Man1,2,
Mei Ling J.N. Chu1, Kayleigh Arp1, Rebecca L. Watson4, Elisabeth A.M. Sanders1,3, Susana Fuentes 3,5 &
Debby Bogaert1,4,5*
The early-life microbiome appears to be affected by mode of delivery, but this effect may
depend on intrapartum antibiotic exposure. Here, we assess the effect of delivery mode on
gut microbiota, independent of intrapartum antibiotics, by postponing routine antibiotic
administration to mothers until after cord clamping in 74 vaginally delivered and 46 cae-
sarean section born infants. The microbiota differs between caesarean section born and
vaginally delivered infants over the ﬁrst year of life, showing enrichment of Biﬁdobacterium
spp., and reduction of Enterococcus and Klebsiella spp. in vaginally delivered infants. The
microbiota composition at one week of life is associated with the number of respiratory
infections over the ﬁrst year. The taxa driving this association are more abundant in
caesarean section born children, providing a possible link between mode of delivery and
susceptibility to infectious outcomes.
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The impact of the human microbiome on health is becomingincreasingly clear, with perturbations being associated withvarious (immune) disorders ranging from allergies and
obesity to inﬂammatory bowel disease1. The gastrointestinal (GI)
tract is of particular relevance to human health, as it contains the
majority and most diverse set of human commensal bacteria2.
Early-life gut microbiota development is crucial for a balanced
priming of the immune system, which occurs early in life in the
so-called window of opportunity3. Mode of delivery is considered
a critical inﬂuential factor on gut microbiota development. Birth
by caesarean section (CS) has been associated with adverse effects
on immune development, predisposing to infections, allergies,
and inﬂammatory disorders4–6. The rising incidence of CS births
is alarming, reaching up to 40.5% of all births in some countries7.
Research into the impact of CS birth on microbiota and health
argues that results may be largely affected by intrapartum anti-
biotics8. Furthermore, the diminished success of breastfeeding
after CS9 adds to alterations in normal microbiota development10.
In our study, we investigate a cohort of 120 healthy children
not directly exposed to intrapartum antibiotics (Microbiome
Utrecht Infant Study [MUIS]). In case of CS delivery, mothers
were administered perioperative prophylaxis only after clamping
of the umbilical cord, making it possible to focus on the inde-
pendent effects of delivery mode on the gut microbiota. The
infants were intensively sampled directly after birth throughout
the ﬁrst year of life. Fecal samples were collected from mothers,
and a broad scale of clinical data and environmental and lifestyle
characteristics was obtained for all participants. Primarily, we
characterized the infant fecal microbiota composition and
dynamics over the ﬁrst year of life and assess, next to delivery
mode, the effect of multiple variables, such as feeding type and
early-life antibiotic use. Secondarily, we assess the effect of the
observed delivery mode-induced gut microbiota alterations on
infant health.
Here, we report on differences in the fecal microbiota between CS
and vaginally delivered (VD) infants over the ﬁrst year of life,
independent of maternal antibiotics. In VD infants, we ﬁnd evi-
dence for fecal microbiota seeding from mother to infant and a
more stable microbiota development in early-life compared with CS
infants. Regarding speciﬁc taxa, VD infants show, among others, an
enrichment of health-associated Biﬁdobacterium spp., and a
reduction of potentially pathogenic Enterococcus and Klebsiella spp.
The overall microbiota composition differs most pronouncedly
between the delivery mode groups at 1 week of age. At this early
timepoint, the microbiota composition is associated with the
number of respiratory infections (RIs) a child will suffer from in the
ﬁrst year of life. Taxa strongly associated with more RIs are more
abundant in CS children, providing a possible link between mode of
delivery and susceptibility to infectious outcomes.
Results
Population characteristics. In our study population, 74 children
were VD, and 46 children were born by CS. Of those, 36 (78%)
were born by planned, and 10 (22%) by emergency CS. There
were two cases of pre-/intrapartum antibiotics, one in each
delivery mode group, indicated for maternal fever, both of which
were included in the analyses. All but three children were born in
the hospital. Baseline characteristics and cumulative disease
parameters over the ﬁrst year of life of all children, stratiﬁed by
mode of delivery, are shown in Table 1. Clinical variables were
evenly distributed over both groups with the exception of gesta-
tional age (two-sample t test, p= 0.003), duration of ruptured
membranes (p= 0.019), hospital stay duration (Wilcoxon test,
p < 0.001), and total duration of breastfeeding in the ﬁrst year of
life (p= 0.014), all being intrinsically related to delivery mode.
The number of children receiving exclusive formula feeding did
not differ between the two groups. Only 36 children (30%)
received antibiotics during their ﬁrst year of life, some receiving
multiple courses (56 courses in total for all children), mostly
(80%) indicated for RIs.
Microbiota composition and mode of delivery. Of the 1243 fecal
samples available from our 120 participants and their mothers,
1139 (92%) passed the quality criteria for further analysis fol-
lowing DNA extraction and 16S rRNA-based sequencing of the
V4 hypervariable region (Supplementary Fig. 1), representing
70,886,595 high-quality reads in total. The Good’s coverage of the
included children’s samples was high, with a minimum of 99.56%
(median 99.96%). The raw Operational Taxonomical Unit
(OTU)-table contained 623 OTUs distributed over seven bacterial
phyla, with the Firmicutes generally being the most prominent
phylum.
We observed that the infants’ overall microbial community
composition developed slowly toward an adult-like proﬁle
(mothers’), though had not yet reached full maturation to an
adult-like composition at 12 months of age (Fig. 1a). This was
illustrated by a steady decrease in Bray–Curtis (BC) dissimilarity
index between infants’ and mothers’ samples over time, with a
median index of 0.999 directly postpartum, which reached 0.739
at the end of the ﬁrst year (Supplementary Table 1). We observed
clear differences in the early development of the overall
community composition between VD and CS children, with a
maximum effect of delivery mode at 1 week of life (permutational
multivariate analysis of variance [PERMANOVA] test, R2
= 0.142, adjusted p-value 0.003, Benjamini–Hochberg method11)
and signiﬁcant differences until the age of 2 months (R2 = 0.021,
adjusted p-value 0.055), after which these differences gradually
disappeared (Fig. 2). To rule out this ﬁnding was due to the
indirect exposure of CS children to maternal antibiotics through
breastfeeding, we repeated this analysis post hoc on a subset of 11
VD and 11 CS children who received exclusive formula feeding.
We observed similar (at some timepoints even bigger) effects (R2)
of delivery mode on overall community composition until
2 months of life within this subset. The association between
delivery mode and composition was still signiﬁcant at 1 week
(Fig. 2; Supplementary Table 2; R2 = 0.215, adjusted p-value
0.008) and 2 weeks of life (R2 = 0.152, adjusted p-value 0.044) in
the exclusively formula fed children. For the whole study
population, we also found that the microbial community in VD
children was more stable when compared with CS children until
2 months of life (Fig. 1b). The BC dissimilarity between
consecutive samples until 4 months was higher in CS, compared
with VD children (Mann–Whitney test, p < 0.001, p= 0.001, and
p= 0.042, for the intervals 1–2 weeks, 2 weeks–1 month and
1–2 months, respectively). In general, alpha diversity increased
directly after birth, and again after 4 months of life, coinciding
with the age that solid food was introduced to the children’s diet
(median= 128 days, IQR= 119.8–164.2 days). There were no
signiﬁcant differences in alpha diversity between the two delivery
mode groups at any timepoint (Supplementary Fig. 2). When
testing the effect of delivery mode on alpha diversity long-
itudinally with a mixed effect model, no signiﬁcant effect was
found (ANOVA, p= 0.511), and neither did feeding type have an
effect in this model (p= 0.652).
Covariates that were signiﬁcantly associated with fecal microbiota
composition over time, as tested with the adonis2 function12
(PERMANOVA test) were, besides mode of delivery (R2= 0.013,
adjusted p-value= 0.001): age (R2= 0.034, adjusted p-value=
0.001), breastfeeding (R2= 0.007, adjusted p-value= 0.001),
daycare attendance (R2= 0.006, adjusted p-value= 0.001), siblings
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< 5 years of age (R2= 0.006, adjusted p-value= 0.001), paciﬁer use
(R2= 0.005, adjusted p-value= 0.003) and antibiotics in the 4 weeks
prior to sampling (R2= 0.003, adjusted p-value= 0.03). Pets in the
household (R2= 0.006, adjusted p-value= 0.061) and duration of
hospital stay after birth (R2= 0.002, adjusted p-value= 0.061)
showed a trend toward being associated with fecal microbiota
composition over time (Supplementary Fig. 3).
Fecal microbiota seeding from mother to infant. To study the
existence of direct maternal fecal microbiota seeding during birth,
and to assess the role of delivery mode herein, we studied the
concordance of the microbiota composition of children’s fecal
samples and their mother’s microbiota over time, in relation to
the concordance with other mothers’ samples. Using a linear
mixed model, we found that an infant’s fecal microbiota com-
position was signiﬁcantly more similar to that of its own mother
than to that of other mothers in VD children when studied over
the entire ﬁrst year of life (ANOVA, p= 0.025; Fig. 3), but not in
CS children (p= 0.271). This difference between groups seemed
independent of the intravenous antibiotics administered to the
mothers in the CS group after cord clamping, as the overall fecal
Table 1 Baseline characteristics
Vaginal birth C-section birth p
n (%) 74 (61.7) 46 (38.3)
Gender, female (%) 39 (52.7) 24 (52.2) 1.000
Gravidity mothers, median (IQR) 2.00 (1.00, 3.00) 2.00 (2.00, 2.75) 0.638
Gestational age in weeks, mean (SD) 39.75 (1.21) 39.12 (0.84) 0.003
Birth weight in grams, mean (SD) 3490.41 (485.87) 3618.00 (459.18) 0.156
Ruptured membranes in hours, mean (SD) 7.32 (9.82) 3.05 (8.39) 0.019
Apgar score at 5 min (%) 0.737
6 1 (1.4) 0 (0.0)
7 2 (2.7) 1 (2.2)
8 1 (1.4) 2 (4.3)
9 10 (13.7) 8 (17.4)
10 59 (80.8) 35 (76.1)
Season of birth (%) 0.557
Winter 13 (17.6) 12 (26.1)
Spring 17 (23.0) 12 (26.1)
Summer 29 (39.2) 13 (28.3)
Fall 15 (20.3) 9 (19.6)
Hospital stay in dayparts, median (IQR) 3.00 (1.00, 4.75) 12.00 (9.50, 14.00) <0.001
Number of siblings, median (IQR) 1 (1.00, 1.00) 1 (0.00, 1.00) 0.264
Presence of siblings < 5 years of age (%) 40 (54.1) 28 (60.9) 0.587
Presence of pets (%) 0.910
None 41 (55.4) 25 (54.3)
Cat(s) 16 (21.6) 11 (23.9)
Dog(s) 6 (8.1) 4 (8.7)
Cat(s) and dog(s) 3 (4.1) 3 (6.5)
Other 8 (10.8) 3 (6.5)
Inhouse smoking (%) 1 (1.4) 2 (4.3) 0.674
Parents ﬁnished higher education (%) 60 (81.1) 31 (67.4) 0.138
Breastfeeding in days, median (IQR) 132.50 (7.00, 310.25) 25.00 (1.00, 124.00) 0.014
Exclusive formula feeding (%) 11 (14.9) 11 (23.9) 0.316
Age start solid food in days, median (IQR) 130.50 (118.25, 165.00) 128.00 (120.00, 163.00) 0.816
Paciﬁer use at 1 month of age (%) 53 (71.6) 33 (71.7) 1.000
Antibiotic use in 1st year of life (%) 19 (26.0) 17 (37.8) 0.254
Number of antibiotic courses, median (IQR) 0.00 (0.00, 0.75) 0.00 (0.00, 1.00) 0.119
Daycare since (%) 0.743
2 months 1 (1.4) 0 (0.0)
3 months 18 (24.3) 11 (24.4)
4 months 14 (18.9) 12 (26.7)
6 months 8 (10.8) 7 (15.6)
9 months 9 (12.2) 3 (6.7)
12 months 1 (1.4) 0 (0.0)
>12 months 23 (31.1) 12 (26.7)
Fever, median (range) 2.00 (0.00, 4.00) 2.00 (0.00, 5.00) 0.448
Nausea postpartum, median (range) 0.00 (0.00, 2.00) 0.00 (0.00, 1.00) 0.541
Constipation, median (range) 0.00 (0.00, 5.00) 0.00 (0.00, 5.00) 0.496
Diarrhea, median (range) 0.00 (0.00, 2.00) 0.00 (0.00, 2.00) 0.108
Vomiting, median (range) 0.00 (0.00, 3.00) 0.00 (0.00, 1.00) 0.505
Thrush, median (range) 0.00 (0.00, 4.00) 0.00 (0.00, 3.00) 0.316
Respiratory tract infections (%) 0.100
0–2 30 (41.1) 11 (24.4)
3–7 43 (58.9) 34 (75.6)
Baseline characteristics stratiﬁed by mode of delivery. Categorical variables are shown in absolute numbers with percentages (%); continuous, normally distributed variables as means with standard
deviations (SD); continuous, non-normally distributed variables as medians with interquartile ranges (IQR) or ranges where speciﬁed. Two sample t tests were used to compare means of normally
distributed continuous variables; Wilcoxon rank-sum tests were applied to compare medians of non-normally distributed continuous variables; signiﬁcant differences between categorical variables were
tested with chi-square tests. The p-values of variables that differed signiﬁcantly between the two groups are in bold and italicized for clarity. Source data are provided as a Source Data ﬁle
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microbiota composition of CS and VD mothers themselves did
not differ shortly after birth (PERMANOVA test, R2= 0.013, p=
0.351; Supplementary Fig. 4).
Dynamics of microbiota development. The succession pattern of
bacterial taxa in the VD children in our study population was
consistent with the description of normal early-life gut microbiota
development in previous studies (Fig. 4a)13,14. Facultative anae-
robic genera, such as Escherichia, and Staphylococcus were highly
abundant in the earliest samples, gradually making way for a
predominance of the genus Biﬁdobacterium. Using smoothing
spline analysis of variance (SS-ANOVA), we observed, among
others, that Biﬁdobacterium was more abundant in VD than in
CS children from day 1 until day 30, even when correcting for
breastfeeding (adjusted p-value 0.003; Supplementary Table 3).
Also, Escherichia was more abundant in VD compared with CS
born children in the ﬁrst 85 days of life. In contrast, in CS chil-
dren we found, among others, higher abundances of Klebsiella
from birth to day 139 and Enterococcus between 7 and 35 days
(both adjusted p-values 0.003). The dynamics of differences in
Biﬁdobacterium, Escherichia, Klebsiella, and Enterococcus over
time are visualized in Fig. 4b, underlining the effect size and
duration of differences.
To conﬁrm that these results were not the consequence of
indirect antibiotic exposure of infants through breast milk, we
executed a post hoc SS-ANOVA analysis for the subset of
exclusively formula fed children. We analyzed the top ﬁve most
abundant taxa over the ﬁrst 2 months of life, and again found an
increased abundance of Biﬁdobacterium (days 5–44, adjusted
p-value= 0.003) in VD infants, and an increased abundance of
Klebsiella in the CS born infants (days 10–20, adjusted p-value
0.020). Also, Staphylococcus was found to be more abundant in
the CS children from 0 to 6 days (adjusted p-value= 0.020).
We used mixed effect models to study the potential associa-
tions between delivery mode, age, feeding type, antibiotic use and
hospital stay duration, and the ﬁve most abundant taxa. We
found that the abundance of Biﬁdobacterium was associated with
mode of delivery (ANOVA, p= 0.004), age (p < 0.001), and
breastfeeding (p < 0.001). Surprisingly, breastfeeding did not
compensate for the lack of Biﬁdobacterium in children born by
CS: children born by CS and receiving breastfeeding had less
Biﬁdobacterium present in their fecal samples than formula fed
VD children (at 1 week of life, Wilcoxon test, p < 0.001, median
relative abundance 0.016 and 45.1%, respectively). The triad CS
birth, age, and formula feeding were also positively associated
with the abundance of Enterococcus and Klebsiella. In addition,
Klebsiella abundance was positively associated with having
received antibiotics in the previous 4 weeks of life (p= 0.001).
Escherichia abundance was only associated with vaginal delivery
(p= 0.003) and age (p < 0.001). Staphylococcus abundance was
associated with age and breastfeeding (both p < 0.001), but not
with delivery mode. We did not ﬁnd an association between
duration of hospital stay after birth and any of these taxa.
Among the remaining mode of delivery-associated taxa
observed (see Supplementary Table 3), we found to be of
particular interest that Bacteroides spp., which are considered to
be important regulators of intestinal immunity15, were more
abundant in the VD compared with CS children in the ﬁrst
months of life.
Delivery mode-induced microbiota changes and infant health.
Since delivery mode is reported to be associated with infant and
childhood health, especially regarding respiratory illness16, we
deﬁned a secondary research question, namely whether gut
microbiota development is associated with health outcome.
Although it was not our aim to study differences in health out-
comes between the delivery mode groups in our cohort, we did
ﬁnd a trend toward differences in infectious disease and treat-
ment parameters, speciﬁcally parent-reported RI events and
antibiotic courses over the ﬁrst year of life (Table 1, chi-square
test, p= 0.119 and p= 0.100, respectively). Exploring this further
with a temporal post hoc analysis, we additionally found a trend
toward a lower hazard ratio for antibiotic prescriptions in VD
children in the ﬁrst year of life (Cox proportional hazard model,
HR= 0.606, p= 0.134).
Altogether, these results supported the validity of our secondary
aim to investigate the potential role of delivery mode-induced gut
microbiota changes on health. To test this, we studied the
association between fecal microbiota composition at 1 week of life
(where the maximum effect of mode of delivery on microbiota
composition was observed; Fig. 2), and all commonly observed
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Fig. 1 Overall gut microbiota community composition development and
stability. a Nonmetric multidimensional scaling (nMDS) plot, based on
Bray–Curtis (BC) dissimilarity between samples, with data points and
ellipses colored by timepoint. Children’s overall gut community
composition developed toward a more adult-like pattern in the ﬁrst year of
life, becoming more similar to microbiota of adults (mothers’ samples, n=
87). b As measure of stability, we calculated BC dissimilarities between
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0.95 conﬁdence intervals. Stability was signiﬁcantly lower in C-section born
infants until 2 months of life. Source data are provided as a Source Data ﬁle
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health parameters in the ﬁrst year of life. We categorized the
number of RI events into 0–2 vs. 3–7 RIs, based on previous studies
of the respiratory microbiome within this same cohort17,18. In these
studies, RIs were initially categorized into three groups based on the
normal distribution of this variable. The 0–2 RIs group was found
to have the most stable development of the nasopharyngeal
microbiota when compared with children suffering from >2 RIs
in the ﬁrst year of life, and was deﬁned as the healthy reference
group. While there were no correlations between microbiota
composition and GI complaints, we observed an association
between microbiota composition at 1 week of life and the
categorized number of RI events (0–2 vs. 3–7 RI events:
PERMANOVA test, R2= 0.033, adjusted p-value= 0.028) as well
as number of antibiotic courses prescribed over the ﬁrst year (R2=
0.024, adjusted p-value= 0.055). These two outcomes were related,
as the antibiotics prescribed were mostly indicated for RIs. We next
aimed to identify the taxa explaining this association between
microbiota composition at 1 week and fewer RI events later in life
by cross-sectional differential abundance analysis, while adjusting
for mode of delivery. We observed, among others, Biﬁdobacterium
to be associated with fewer RI events (0–2 vs. 3–7 RI events, zero-
inﬂated Gaussian mixture model, log2 fold change (log2FC) 2.118,
adjusted p-value 0.049, Fig. 5), whereas Klebsiella and Enterococcus
were negatively associated with fewer RI events (log2FC −3.242,
adjusted p-value= 0.007 and log2FC −2.838, adjusted p-value=
0.009, respectively). Other taxa found to be negatively associated
with fewer RI events encompassed genera such as Veillonella and
Staphylococcus. Random forest analysis was used to verify these
results and identiﬁed once again Enterococcus, Biﬁdobacterium, and
Klebsiella as the most important taxa driving the prediction of the
categorized RI events in the ﬁrst year of life (Supplementary
Table 4). Furthermore, a stratiﬁed analysis for the VD and CS
groups separately, showed similar associations between gut
microbiota composition at 1 week of life and number of RI events
for the two groups (PERMANOVA test, R2 0.003 and 0.005,
p-value 0.040 and 0.068, respectively). Taxa associated with the
number of RI events were comparable between the overall and
stratiﬁed analyses, although for VD children we now only found
signiﬁcance for Enterococcus (zero-inﬂated Gaussian mixture
model, log2FC −2.525, adjusted p-value 0.074), whereas for the
CS children, Biﬁdobacterium (log2FC 2.805), Klebsiella (log2FC
−6.991) and Enterococcus (log2FC; −4.283) were all signiﬁcantly
associated with number of RIs (adjusted p-values 0.055, 0.010, and
0.055, respectively).
Validation of the results with metagenomics and targeted
qPCR. To validate our primary ﬁndings independently, we exe-
cuted whole genome shotgun (WGS) sequencing on a subset of
20 randomly selected samples collected at 1 week of life from 10
VD and 10 CS born children. WGS sequencing yielded a total of
137 unique bacterial taxa. The relative abundances of the top 12
OTUs and species of both sequencing methods are represented in
Supplementary Fig. 5, and show highly comparable proﬁles. The
most abundant Biﬁdobacterium species in the WGS data set were
B. longum, B. breve, and B. adolescentis. The combined relative
abundances of these three species strongly correlated with the
most abundant Biﬁdobacterium of the 16S rRNA data set
(Pearson’s r 0.95, adjusted p-value < 0.001). In this way, we could
also correlate the E. coli, Staphylococcus, Klebsiella, and E. faecium
OTU abundance of the 16S rRNA data set with high certainty to
the E. coli, S. epidermidis, K. oxytoca, and E. faecium species
abundance in the WGS data set (Supplementary Table 5).
We also used the WGS sequencing data to validate the
differences found by 16S rRNA sequencing in overall gut
microbiota composition between VD and CS born children at
1 week of life. The results from the ordination using the WGS
sequencing data are shown in Supplementary Fig. 6. Again, we
found a signiﬁcant effect of delivery mode on the overall gut
microbiota composition at 1 week of life using WGS sequencing
data (PERMANOVA test, R2 = 0.125, p= 0.01).
Next, we compared the microbiota proﬁles obtained by WGS
sequencing between VD and CS children and observed that the
combination of B. breve, B. longum, and B. adolescentis (median
relative abundance 72.2% in the VD vs. 0.074% in the CS born
children, Wilcoxon test, p= 0.002), K. oxytoca (<0.001 vs.
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0.006%, p= 0.153) and E. faecium (0.014 vs. 0.035%, p= 0.023)
were differentially abundant between groups. In this data set,
E. coli and S. epidermidis did not differ signiﬁcantly between the
delivery mode groups.
To alternatively validate our results on the overall cohort and
in a targeted manner, we performed qPCR analyses for E. coli,
Klebsiella spp. and Enterococcus spp. on all week 1 samples (n=
119). The qPCR results conﬁrmed that E. coli is more commonly
present in VD children compared with CS children (chi-square
test, p < 0.001), whereas CS children are more often colonized
with Klebsiella spp. (p= 0.011) and Enterococcus spp. (p= 0.004)
than VD children, corroborating the 16S rRNA and WGS
sequencing results (Supplementary Table 6). Finally, qPCR also
conﬁrmed that colonization with Enterococcus spp. and Klebsiella
spp. at 1 week of life was positively associated with more RI
events in the ﬁrst year of life, though this difference was only
signiﬁcant for Enterococcus spp. (p= 0.015, Supplementary
Table 7).
Discussion
In this study, we were able to investigate the effect of mode of
delivery on fecal microbiota development in healthy children,
independent of maternal antibiotic exposure, as antibiotics given
perioperatively for CS were postponed to after cord clamping. We
here describe the dynamics of the fecal microbiota in the ﬁrst year
of life in relation to mode of delivery and assess how early-life
mode of delivery-induced microbiota alterations might affect
susceptibility to RIs in the ﬁrst year of life.
We found substantial differences in the gut microbiota com-
position and stability between VD and CS children, especially in
the ﬁrst months of life, with notably Biﬁdobacterium being more
abundant in VD children, consistent with literature19–23. Biﬁdo-
bacteria are health-associated microbes well-known for their use
as probiotics24. They promote gut health and provide defense
against pathogens1. We found that in children born by CS, the
colonization with Biﬁdobacterium was signiﬁcantly delayed,
which was not affected by feeding type. This suggests that
maternal transmission during vaginal delivery is essential in
acquiring these bacterial species in early life4, which was sup-
ported by the evidence we found for fecal seeding from mother to
child in the VD, but not in CS children. Perhaps therefore not
solely vaginal microbiota seeding25 but also fecal microbiota
seeding during vaginal delivery is instrumental in shaping the
newborn’s gut microbial environment. These data suggest that
only after proper initial (vaginal-)fecal seeding takes place, the
growth of beneﬁcial groups such as Biﬁdobacterium can be pro-
moted, which can be further enhanced through the prebiotic
Bifidobacterium (1)
Klebsiella (4)
Enterococcus faecium (5)
Streptococcus pyogenes (26)
Clostridium butyricum (33)
Erysipelotrichaceae (45)**
Bacteroides (48)
Bacteroides (65) Veillonella (179)
Actinomyces (194)
Eggerthella (202)*
Finegoldia (203)
Bifidobacterium (237)
Enterobacteriaceae (242)
Bacteroides (245)
Bifidobacterium (246)
Enterococcaceae (251)
Bacillales (255)
Enterococcus (256)
Veillonella (275)
Bacteroides (279)
Bifidobacteriaceae (309)
Veillonella (366)
Staphylococcaceae (382)
Ruminococcus gnavus (404)
Bifidobacteriaceae (430)
Bacteroides (433)
Enterobacteriaceae (473)
Staphylococcus (530)
Streptococcus salivarius subsp thermophilus (554)
0
2
4
6
8
−2 0 2
Fold change (log)
Ad
jus
ted
 P
−
va
lu
e 
(lo
g1
0)
3−7 RI events Not significant 0−2 RI events
Fig. 5 Differentially abundant taxa between 0-2 vs. 3-7 RI events in ﬁrst year of life. To identify taxa that were differentially abundant between children
experiencing more vs. limited respiratory infection (RI) events over the ﬁrst year of life, ﬁtZig analysis was performed on the 119 samples obtained at week 1
with the rare-features-ﬁltered OTU-table containing 97 taxa and contrasts set to 0–2 vs. 3–7 RI events in the ﬁrst year of life. The blue data points indicate
taxa that were signiﬁcantly more abundant in children having 0–2 RI events, while red points represent taxa that were signiﬁcantly more abundant in
children with 3–7 RI events in the ﬁrst year of life. The results of two data points falling beyond the limits of the plot: *Eggerthella log2FC 3.512, adjusted p-
value (log10) 7.357, **Erysipelotrichaceae log2FC 6.912, adjusted p-value (log10) 6.222, calculated using a zero-inﬂated Gaussian mixture model. Source
data are provided as a Source Data ﬁle
ARTICLE NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-13014-7
8 NATURE COMMUNICATIONS |         (2019) 10:4997 | https://doi.org/10.1038/s41467-019-13014-7 | www.nature.com/naturecommunications
oligosaccharides present in breast milk26. Hence, the stimulation
of breastfeeding in women that have delivered by CS, or the
advances in prebiotic formulations of modern formula milk,
might not be able to correct the lack of Biﬁdobacterium seeding
during delivery, as we saw that breastfed CS infants carried these
bacteria in lower abundance than formula fed VD infants. Our
data also suggest that this lack of Biﬁdobacterium is not the
consequence of antibiotic exposure intrapartum, but merely a
consequence of delivery mode itself, which was further supported
by the sub-analysis on formula fed infants, limiting the likelihood
of exposure to maternal antibiotics through breast milk. Impor-
tantly, the delay in Biﬁdobacterium establishment may have a
major impact on the infants’ early life and future health, as the
window of opportunity for immune priming occurs within the
ﬁrst 100 days of life27.
While Biﬁdobacterium was abundantly present in the fecal
samples of VD children, the potential pathogenic and proin-
ﬂammatory Klebsiella and Enterococcus were more abundant in
children born by CS, which is in accordance with previous
studies22,28. For Klebsiella, the difference in abundance lasted for
more than 4 months, long after the initial neonatal period.
Recently, an increased Klebsiella/Biﬁdobacterium ratio in early life
was correlated with later development of pediatric allergy29. This
could be an important link between mode of delivery and
increased prevalence of pediatric allergies following CS birth. In
addition, bacteria from the Klebsiella genus are a common cause
of nosocomial infections and act as a reservoir for a diverse scale
of antimicrobial resistance genes30,31. It is highly likely that the
Klebsiella bacteria found in our study population were acquired
from the hospital (operating room) environment, and in the
absence of a stable environment, thrived in the gut of CS infants.
These ﬁndings might thus imply that mode of delivery not only
increases the risk for immunological disorders, but also the risk
for (antibiotic resistant) infections.
Although our study was not powered to investigate differences
in overall health outcomes between VD and CS children, we still
found a trend toward more RI events and a higher need for
antibiotics in the ﬁrst year of life in CS compared with VD
children. This early timeframe is clinically important, as early
onset of RI is considered a risk factor for recurrent infections32,33.
As CS incidence is speciﬁcally rising in Latin American
countries7, in future studies it would be of interest to assess
socioeconomic factors as a link between mode of delivery,
maternal microbiota characteristics, choice of feeding type and
early-life risk of infection.
Uniquely to our study, we were able to relate the fecal
microbiota composition at a very early age (one week), where the
microbiota differences between mode of delivery groups were
largest, to RI events occurring in the ﬁrst year of life. Our stra-
tiﬁed analyses per delivery mode group showed similar results to
the overall cohort analysis, with especially Biﬁdobacterium,
Klebsiella, and Enterococcus being associated with RI events
independent of mode of delivery, though effect sizes were larger
in the CS group. One reason for this could be a mediating effect
of breastfeeding with mode of delivery, since breastfeeding is less
common in CS children, and has a known protective and inde-
pendent effect against infectious diseases34.
Although these results require validation in preferentially lar-
ger cohorts, our ﬁndings do suggest that early-life gut microbiota
composition might play a role in systemic (immune-mediated)
resistance against infectious diseases. We found that especially
early-life presence and abundance of Klebsiella and Enterococcus
species, belonging to the ESKAPE pathogen family35, show a
relation with the development of a higher incidence of RI events
later in life, whereas Biﬁdobacterium and certain Bacteroides
species might play a protective role. Potential mechanisms by
which biﬁdobacteria may protect against pathogens and resulting
infections is through increasing the local pH and indirectly
through increasing the short-chain fatty acid abundance in the
gut, promoting gut health1.
Strengths of our study include high sampling frequency, the
broad scale of clinical and epidemiological data collected con-
sistently by trained research nurses, the quality of the sequencing
data enabling us to maintain a strict ﬁltering threshold, and the
longitudinal character of our study combined with the use of
differential abundance testing, providing us with enough statis-
tical power to discern differences in both microbial succession
patterns and disease parameters between delivery mode groups.
The most important limitation of our study is the limited
number of samples from the postpartum timepoint that elicited
sufﬁcient amounts of DNA for characterization of the microbiota,
though, inherent to the low dense colonization in neonates in
general, this is unlikely to have introduced confounding. Also,
sequencing of the V4 hypervariable region of the 16S rRNA gene
does not allow for conﬁdent reporting of results on a lower tax-
onomical level than genus level, though this was in part resolved
by WGS sequencing validation of a subset of 20 samples. Finally,
our observational study was not primarily designed to investigate
health differences between delivery mode groups, therefore the
power to research correlations between drivers, biomarkers, and
health consequences was limited.
In conclusion, we here report on modest differences in health
characteristics between delivery mode groups, where children
born by CS show a tendency toward higher incidence of RI events
in early life, as well as a trend in higher need for antibiotics than
VD children, with the former being linked to differences in
abundance of several biomarker bacteria. In CS delivered chil-
dren, the gut microbiota appears less stable with the acquisition of
Biﬁdobacterium being delayed when compared with VD children.
This delay is independent of feeding type, suggesting that
maternal transmission during vaginal delivery is essential in
acquiring these bacterial species in early life, which is further
supported by the evidence for fecal seeding in the VD children,
but not in CS children in our study. The abundance of potential
pathogens from the genera Klebsiella and Enterococcus is higher
in children born by CS, and independent of prenatal antibiotic
exposure, duration of hospitalization, and feeding type. These
taxa are also associated with a higher incidence of RI events in the
ﬁrst year of life. These ﬁndings provide evidence for a possible
link between mode of delivery-induced alterations in the infant
gut microbiota and susceptibility to (infectious) diseases.
Methods
Study population and sample collection. Data and fecal samples were available
from 120 children, of which 74 were vaginally delivered (VD) and 46 born by
caesarean section (CS), and their mothers, who had participated in the prospective
Microbiome Utrecht Infant Study (MUIS) consisting of healthy, full term Dutch
children36. These 120 children had all (1) completed the 1-year follow-up (except
for two children, for whom samples were only collected until 6 months, after which
they dropped out due to moving out of the area) and (2) had at least ﬁve fecal
samples available from ten timepoints. Recruitment took place during pregnancy
and written informed consent was obtained from both parents. Ethical approval
was granted by the national ethics committee in the Netherlands, METC Noord-
Holland (committee on research involving human subjects, M012-015, NTR3986).
The study was conducted in accordance with the European Statements for Good
Clinical Practice. The study had originally been powered based on the abundance
and distribution of previously published microbiota data from infants37, ensuring a
power of 0.8 to detect at least signiﬁcant differences in alpha and beta diversity
between groups, as well as differences in abundance of the 25 most important
operational taxonomical units (OTUs), taking into consideration OTUs with high
and low variability and abundance and varying effect sizes. This power calculation
was later veriﬁed by an online (Human Microbiome Project based) tool38. We
initially aimed to enroll 88 infants, 44 infants per delivery mode group, allowing a
dropout of 10%. Due to uneven enrollment in both arms, approval was granted by
the ethical committee to prolong enrollment to ensure sufﬁcient CS recruitment,
simultaneously continuing the parallel enrollment of VD infants to prevent
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seasonal/annual differences in microbiota development between the delivery mode
groups. Eventually, 78 VD and 52 CS children were recruited; 10 (7.7%) dropped
out after an average of 2 weeks of follow-up.
Hospital and home visits took place within 2 h postpartum (pp), 24–36 h after
delivery (d1), at 7 (w1) and 14 (w2) days and at 1, 2, 4, 6, 9, and 12 months (m) of
age. Fecal samples were collected by a nurse during hospitalization or by the
parents prior to the home visits. On a voluntary basis, mothers provided one fecal
sample 2 weeks after childbirth. Sterile fecal containers were used for sample
collection, and parents were instructed to store the material directly at −20 °C in
the (home) freezer. Samples were transported on dry ice and transferred for long-
term storage at −80 °C until further laboratory processing. Extensive
questionnaires on the health status of the children were collected at each visit by
research personnel and additionally at 3 months. At baseline, information was
collected on prenatal and perinatal characteristics.
Respiratory infection (RI) events were deﬁned as occurrence of fever (>38.0°) in
combination with any of the following parent-reported symptoms: cough,
wheezing, dyspnea, earache, or malaise. Gastrointestinal (GI) complaints were
categorized into: postpartum nausea, constipation, diarrhea, and vomiting and
were noted as being either present or absent since the previous home visit. For each
symptom, occurrences over the ﬁrst year were summed up to a cumulative number.
DNA isolation and sequencing. Fecal samples were thawed and homogenized by
vortexing. For bacterial DNA extraction ~100 μl of raw feces was added to 300 μl of
lysis buffer (Agowa Mag Mini DNA Isolation Kit, LGC ltd, UK), 500 μl of 0.1-mm
zirconium beads (BioSpec products, Bartlesville, OK, USA) and 500 μl of phenol
saturated with Tris-HCl (pH 8.0; Carl Roth, GMBH, Germany) in a 96-wells plate.
The samples were mechanically disrupted using a Mini-BeadBeater-96 (BioSpec
products, Bartlesville, OK, USA) for 2 min at 2100 oscillations per minute. DNA
puriﬁcation was performed using the Agowa Mag Mini DNA Isolation Kit
according to the manufacturer’s recommendations. The extracted DNA was eluted
in a ﬁnal volume of 60 μl of elution buffer (LGC Genomics, Germany). Samples
collected directly postpartum and on day 1 were presumed to have low bacterial
abundance and diversity. Therefore, adaptations in the standard DNA isolation
procedure were applied: 150 μl of raw feces was added to 350 μl of lysis buffer, and
bead beating was done for 2*3 min. In total, 300 μl of the aqueous layer was used
for extraction with the Agowa Mag Mini DNA Isolation Kit, the binding time of
DNA to the magnetic beads was prolonged to 30 min, the magnetic beads were
washed twice with wash buffer 1, and the extracted DNA was eluted in a ﬁnal
volume of 40 μl of buffer. As the yield of these early samples was low, another
round of DNA isolation was performed on the aliquots of this set with an altered
protocol: a small loop of feces (~150 μl, or 100 μl when liquid) was added to 650 μl
lysis buffer including zirconium beads and 600 μl of phenol, and the whole aqueous
layer was used. DNA blanks and feces pools consisting of a mix of up to three
random samples served as controls. The amount of bacterial DNA was determined
by quantitative polymerase chain reaction (qPCR) as described39, using primers
speciﬁc for the bacterial 16S rRNA gene (forward: CGAAAGCGTGGGGAGCA
AA; reverse: GTTCGTACTCCCCAGGCGG; Probe: 6FAM-ATTAGATACCCT
GGTAGTCCA-MGB) on the 7500 Fast Real Time system (Applied Biosystems,
CA, USA).
For the sequencing of the V4 hypervariable region of the 16S rRNA gene, 1 ng
of DNA was ampliﬁed using F515/R806 primers and 30 ampliﬁcation cycles40,41.
After ampliﬁcation of the V4 hypervariable region of the 16S rRNA, the amount of
ampliﬁed DNA per sample was quantiﬁed with the dsDNA 910 Reagent Kit on the
Fragment Analyzer (Advanced Analytical, IA, USA). Samples that yielded
insufﬁcient DNA after ampliﬁcation, deﬁned as <0.5 ng per μl, were repeated with a
higher concentration of template DNA. Each PCR plate included a mock control
and three PCR blanks. 16S rRNA sequencing was performed on the Illumina
MiSeq platform (Illumina, Eindhoven, the Netherlands) on a total of 1139 samples
and 85 controls in 17 runs.
Bioinformatic processing. The sequences were processed in our bioinformatics
pipeline, where we applied an adaptive, window-based trimming algorithm (Sickle,
version 1.33) to ﬁlter out low quality reads maintaining a Phred score threshold of
30 and a length threshold of 150 nucleotides42. Error correction was conducted
with BayesHammer (SPAdes genome assembler toolkit, version 3.5.0)43. Each set of
paired-end sequence reads was assembled with PANDAseq (version 2.10) and
demultiplexed (QIIME, version 1.9.1)44,45. Singleton and chimeric reads
(UCHIME) were removed. OTU picking was performed with VSEARCH
abundance-based greedy clustering with a 97% identity threshold46. OTUs were
annotated with the Naïve Bayesian RDP classiﬁer (version 2.2) and the SILVA
reference database47,48. This resulted in an OTU-table containing 6690 taxa. We
made an abundance-ﬁltered data set selecting OTUs present at a conﬁdent level of
detection (0.1% relative abundance) in at least two samples49, henceforth referred
to as our raw OTU-table. The raw OTU-table consisted of 623 taxa (0.4%
sequences excluded with ﬁltering) and was used for the downstream analyses
unless otherwise speciﬁed.
Whole genome shotgun (WGS) sequencing and processing. To validate the
taxonomical annotation of the 16S rRNA sequences and some of our 16S rRNA-
based ﬁndings, we performed whole genome shotgun (WGS) sequencing on a
randomly selected subset of 20 fecal samples collected from 10 VD and 10 CS born
children at the age of 1 week. Samples were prepared using the Truseq Nano gel
free library preparation kit. Using a NovaSeq instrument, 150 base paired-end
sequence data were generated from the libraries to yield 750M+ 750M reads (two
runs). Reads were trimmed using Cutadapt50 (version cutadapt-1.9.dev2) of
amplicon adapter sequences and on quality at the 3′ end maintaining a quality
threshold of 30 and a minimum read length of 35 base pairs. Per sample and per-
run SAM ﬁles were generated with Bowtie251 and the MetaPhlAn252 database
while adhering to recommended parameters and using -no-unal to suppress
reporting unaligned reads and the -very-sensitive parameter. Each SAM ﬁle was
assigned a read group and SAM ﬁles from different runs were merged sample-wise
using Picard53. MetaPhlAn2 was run to identify the bacterial taxa present within
each sample. The SAM ﬁles generated using Bowtie2 were used as input for
MetaPhlAn2, all other parameters were kept as default.
Determination of speciﬁc biomarkers by qPCR. To identify the presence of
E. coli, Klebsiella spp. (including K. oxytoca and K. pneumoniae) and Enterococcus
spp. in all the samples collected at 1 week of age (n= 119), we used the VetMAX™
MastiType Multi Kit (Applied Biosystems™, CA, USA) according to the manu-
facturer’s instructions. The qPCR test results were analyzed with the recommended
Animal Health VeriVet Software, available on Thermo Fisher Cloud. One sample
was discarded from the statistical analyses because its Internal Ampliﬁcation
Control did not pass the Ct-value criteria in three out of the four mixes.
Statistical analyses. A statistical analysis scheme showing the ﬂow in and order of
analyses to address the primary, secondary and exploratory research questions can
be found in Supplementary Fig. 7. All analyses were performed in R version 3.4.354
within RStudio version 1.1.38355, and ﬁgures were made using packages ggplot256
and ggpubr57. For simple, independent comparisons, we considered p-values <0.05
to be signiﬁcant. However, for all analyses regarding multiple comparisons, we
used the Benjamini–Hochberg method to correct for multiple testing11.
For comparisons of group differences, a two-sample t test, Wilcoxon rank-sum
test or chi-square test was used where appropriate. Survival analysis was executed
using the packages survival and survminer58,59. The hazard ratio for antibiotic
administration was calculated with a Cox proportional hazard model.
Group differences in Shannon alpha diversity were calculated with t-tests and a
linear mixed-effect model with participant as random effect while correcting for
age and feeding type. Differences in overall gut bacterial community composition
were visualized with nonmetric multidimensional scaling plots (nMDS; vegan
package12). Ordinations were based on the BC dissimilarity matrix of relative
abundance data with parameter trymax 10,000. The overall gut bacterial
community composition of children born by emergency CS (n= 10) was, although
not fully similar, more similar to that of children born by planned CS
(Supplementary Fig. 8; permutational multivariate analysis of variance
(PERMANOVA) test, R2= 0.005, p= 0.051) than by vaginal birth (R2= 0.006,
p= 0.002). Because the number of children born by emergency CS was too small to
analyze as independent group, we decided to group emergency and planned CS
children together for all delivery mode comparisons.
To study whether the differences in overall gut microbiota community
composition between delivery mode groups were not inﬂuenced by antibiotics
received indirectly through the breast milk from mothers treated prophylactically
after CS, post hoc analyses were performed on a subset of 11 VD and 11 CS infants
that received exclusive formula feeding.
Associations between clinical outcome and microbiota composition were
analyzed with the adonis2 function (vegan package12), based on
PERMANOVA tests per timepoint and across all timepoints using 1999
permutations, including all variables that showed a signiﬁcant association with
microbiota composition when tested individually, namely mode of delivery,
duration of hospital stay after delivery, breastfeeding at time of sampling, paciﬁer
use, antibiotics in the 4 weeks prior to sampling, siblings <5 years in the household,
pets in the household, high education of parents, and daycare attendance. For the
temporal analyses, age and subject were added to control for repeated measures.
To test the occurrence of fecal seeding (i.e., whether the microbiota composition
in VD children was more similar to that of their own mothers than in the CS
group), BC dissimilarities were calculated between children’s and their own
mother’s vs. other mothers’ samples, stratiﬁed per group. We used a linear mixed
model to assess the effect of delivery mode (ﬁxed effect) on BC dissimilarity as a
dependent variable, while including subject as a random intercept to adequately
control for repeated measures and correcting for timepoint, using the lme function
of the nlme package60. P-values of our linear mixed models were extracted using
the ANOVA function.
The stability of the gut microbiota composition in the ﬁrst year of life was
visualized by measuring the BC dissimilarities between consecutive samples within
each participant over time. To test for group differences, the Mann–Whitney test
was used.
Individual bacterial taxa and their succession patterns, and potential differences
thereof between groups, were studied at the lowest taxonomic annotated level
(OTU). Differential abundance testing was executed with smoothing spline analysis
of variance (SS-ANOVA, ﬁtTimeSeries function, metagenomeseq package61,62)
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allowing not only to detect biomarker OTUs related to mode of delivery, but also to
identify the speciﬁc intervals in which signiﬁcant differences existed. For this
analysis, the raw OTU-table was ﬁltered and OTUs with >10 reads in ≥50 samples
were included, resulting in 306 OTUs (of the 623)17. The SS-ANOVA analysis was
adjusted for covariates that both had (1) an effect on overall gut microbiota
composition and (2) were unevenly distributed between the two delivery mode
groups, namely hospital stay duration after birth, breastfeeding at time of sampling
and antibiotic use in the 4 weeks prior to sampling. Although duration of ruptured
membranes and gestational age were associated with mode of delivery, we did not
ﬁnd an association with gut microbiota composition, therefore these two variables
were excluded from downstream ﬁtTimeSeries analyses. A post hoc SS-ANOVA
was performed on the subset of children who were exclusively formula fed,
speciﬁcally testing for differences in the top ﬁve most abundant taxa and focusing
on the ﬁrst 2 months of life, as differences between delivery mode groups overall
were most pronounced in this period.
We used linear mixed models to test the importance of delivery mode, duration
of hospital stay after birth, feeding type, and antibiotic use on the relative
abundance of the top ﬁve most abundant taxa. Using the lme function60, we set the
clinical variables as ﬁxed effects and the arcsine square root transformed relative
abundances of each taxon of interest as dependent variable, adding subject as
random intercept and correcting for age.
To test if the microbiota could predict for cumulative disease parameters
(namely fever episodes, thrush, GI symptoms, RI events, general practitioner and
specialist consultation, and antibiotic prescription) after 1 week of age, we
performed a BC-based PERMANOVA on the overall community composition of
the samples obtained at this sampling moment. The number of RI events in the
ﬁrst year of life was tested as both a continuous and categorical variable grouped in
0–2 and 3–7 episodes, based on previous studies17,18. The ﬁtZig function of the
metagenomeSeq package was used to assess the driving OTUs behind signiﬁcant
predictions62, after removing rare features present in <10 samples, resulting in 97
OTUs included in this analysis. The analysis was adjusted for delivery mode.
Random forest analysis was used to verify these results, setting the categorized
number of RI events as outcome, and the OTUs present in the samples at 1 week of
age as predictors along with delivery mode and variables also adjusted for in the
ﬁtTimeSeries analysis63. We also performed the ﬁtZig analysis in a stratiﬁed
manner for both delivery mode groups.
The results from 16S rRNA sequencing at 1 week of life were validated by
untargeted WGS sequencing (subset of 20 infants) and targeted qPCR (on all 120
infants).
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
Sequence data that support the ﬁndings of this study have been deposited in the NCBI
Sequence Read Archive (SRA) database with BioProject ID PRJNA481243 and
PRJNA555020. The source data underlying Table 1, Fig. 1a, b, 2, 3, 4a, b and 5,
Supplementary Tables 1 and 5–7 and Supplementary Figs. 2, 5, and 6 are provided as a
Source Data ﬁle.
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